Supporting Breakthrough Science
Every investigator at Fred Hutch has access to shared facilities and cutting-edge technologies and expertise that can help speed the process of discovery — and that few individual labs could afford on their own. This multimillion-dollar infrastructure is also accessible to members of the Fred Hutch/University of Washington/Seattle Children's Cancer Consortium, academic and industry research partners, and some other external clients. Cores within Fred Hutch Shared Resources, the Cancer Consortium's Partner Institutions (University of Washington and Seattle Children's), and Fred Hutch scientific divisions are staffed by experts who can help investigators design experiments, choose the most suitable tests and equipment, create customized tests and software tools, and analyze experimental results. In all, they offer dozens of services in addition to access to equipment and tools.
ON THIS PAGE
Shared Resources Cores | Cancer Consortium Partner Institution Cores | Divisional Cores
Antibody Technology*
Internationally recognized team that offers novel monoclonal antibody discovery, production and characterization services.
Biospecimen Processing and Biorepository
Provides investigators with high-quality biospecimen sample processing, DNA/RNA extraction and biorepository services.
Cellular Imaging*
Provides light microscopy services that support both basic and preclinical projects.
Clinical Research Specimen Processing
Provides investigators with processing, storage, and distribution of clinical research specimens.
Comparative Medicine*
Enables high-quality science that proceeds with maximal efficiency, care and regulatory compliance.
Electron Microscopy*
Offers electron microscopy services to resolve structures from cellular ultrastructure to molecular interactions.
Experimental Histopathology*
Provides a range of histology, histochemistry, immunochemistry and pathology services for human tissues and model organisms.
Flow Cytometry*
Offers top-of-the-line cell analysis and cell-sorting services, from single-laser benchtop analysis to mass cytometry and complex multi-laser cell sorts.
Genomics & Bioinformatics*
Provides an integrated, streamlined and expertly supported set of services that encompass experimental design, genomics-based data generation and data interpretation.
Immune Monitoring*
Supports studies of cellular immunity, including assays of cell populations and responses in clinical trials.
Preclinical Imaging*
Provides state-of-the-art in vivo imaging technology and infrastructure to support basic and preclinical studies.
Preclinical Modeling*
Supports the development and maintenance of preclinical mouse models, including xenografts and genetically engineered mouse models.
Proteomics & Metabolomics*
Provides mass spectrometry and high-performance liquid chromatography services for the analysis of proteins and peptides, including metabolomics studies.
Therapeutic Products Program*
Offers development and manufacturing expertise for cell-based therapies for Phase 1/2 clinical testing.